HYDROCORTISONE
| Brand name | KHINDIVI |
|---|---|
| Active ingredient | HYDROCORTISONE |
| Strength | 1MG/ML |
| Dosage form | SOLUTION |
| Route | ORAL |
| Modality | Small molecule |
| FDA approval | May 2025 |
| Marketing status | RX |
| Patent | Expires | Type |
|---|---|---|
| 12133914 | February 2043 | use U-4215 |
| 11904046 | February 2043 | product |
Source: FDA Orange Book, layered on the CliffBio company graph. Cliff dates are the latest FDA-listed patent expiry; estimates are projections, not legal advice.